Literature DB >> 26504753

Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats.

Reza Badalzadeh1, Mustafa Mohammadi1, Bahman Yousefi2, Safar Farajnia3, Moslem Najafi4, Shima Mohammadi2.   

Abstract

PURPOSE: Diabetes mellitus as a main risk-factor of ischemic heart disease may interfere with postconditioning'scardioprotective effects. This study aimed to investigate the involvement of glycogen synthase kinase-3β (GSK-3β) and oxidation status in chronic diabetes-induced loss of cardioprotective effect of ischemic-postconditioning (IPostC) in Wistar rats.
METHODS: After 8 weeks of induction of diabetes by streptozotocin (50mg/kg), hearts of control and diabetic rats were isolated and mounted on a constant-pressure Langendorff system. All hearts were subjected to 30min regional ischemia followed by 60min reperfusion (by occluding and re-opening of left anterior descending coronary artery, respectively). IPostC was applied immediately at the onset of reperfusion. At the end of reperfusion, the infarct size of myocardium was measured via computerized planimetry. Myocardial contents of malondealdehyde and glutathione as indices of oxidative status were assayed spectrophotometrically and the total and phosphorylated forms of myocardial GSK-3β were quantified through western blotting.
RESULTS: IPostC reduced the infarct size of control hearts from 41±2.9% to 28±1.9% (P<0.05), whereas it could not induce significant changes in infarct size of diabetic animals (35±1.8% vs. 39±3.1%). IPostC-induced reduction in malondealdehyde and elevation in glutathione contents were significant only in control not in diabetic hearts. The total forms of GSK-3β were similar in all groups; however, the phosphorylation of GSK-3β (at Ser9) by IPostC was greater in control hearts than diabetics (P<0.01).
CONCLUSION: The failure of cardioprotection by IPostC in diabetic hearts may be attributed to the loss of phosphorylation of GSK-3β and thereby increase in oxidative stress in diabetic states.

Entities:  

Keywords:  Cardioprotection; Diabetes; GSK-3β; Postconditioning; Reperfusion injury

Year:  2015        PMID: 26504753      PMCID: PMC4616890          DOI: 10.15171/apb.2015.045

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  30 in total

Review 1.  Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.

Authors:  S M Grundy; I J Benjamin; G L Burke; A Chait; R H Eckel; B V Howard; W Mitch; S C Smith; J R Sowers
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Anti-arrhythmic effect of diosgenin in reperfusion-induced myocardial injury in a rat model: activation of nitric oxide system and mitochondrial KATP channel.

Authors:  Reza Badalzadeh; Bahman Yousefi; Maryam Majidinia; Hadi Ebrahimi
Journal:  J Physiol Sci       Date:  2014-08-24       Impact factor: 2.781

Review 3.  Role of glycogen synthase kinase-3beta in cardioprotection.

Authors:  Magdalena Juhaszova; Dmitry B Zorov; Yael Yaniv; H Bradley Nuss; Su Wang; Steven J Sollott
Journal:  Circ Res       Date:  2009-06-05       Impact factor: 17.367

Review 4.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

Review 5.  Cardioprotection against ischaemia/reperfusion by vitamins C and E plus n-3 fatty acids: molecular mechanisms and potential clinical applications.

Authors:  Ramón Rodrigo; Juan C Prieto; Rodrigo Castillo
Journal:  Clin Sci (Lond)       Date:  2013-01       Impact factor: 6.124

Review 6.  Postconditioning: reduction of reperfusion-induced injury.

Authors:  Zhi-Qing Zhao; Jakob Vinten-Johansen
Journal:  Cardiovasc Res       Date:  2006-03-20       Impact factor: 10.787

7.  Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta.

Authors:  Claudia Wagner; Ingrid Kloeting; Ruth H Strasser; Christof Weinbrenner
Journal:  J Cardiovasc Pharmacol       Date:  2008-11       Impact factor: 3.105

8.  Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats.

Authors:  Y Yun; W G Duan; P Chen; H X Wu; Z Q Shen; Z Y Qian; D H Wang
Journal:  Transplant Proc       Date:  2009-11       Impact factor: 1.066

Review 9.  Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

Authors:  Peter Ferdinandy; Rainer Schulz; Gary F Baxter
Journal:  Pharmacol Rev       Date:  2007-11-29       Impact factor: 25.468

10.  Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: role of mitochondrial ATP-sensitive potassium channels.

Authors:  Hadi Ebrahimi; Reza Badalzadeh; Mustafa Mohammadi; Bahman Yousefi
Journal:  J Physiol Biochem       Date:  2014-02-18       Impact factor: 4.158

View more
  10 in total

Review 1.  Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.

Authors:  Reza Badalzadeh; Behnaz Mokhtari; Raana Yavari
Journal:  J Physiol Sci       Date:  2015-03-01       Impact factor: 2.781

2.  Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.

Authors:  Reza Badalzadeh; Ako Azimi; Alireza Alihemmati; Bahman Yousefi
Journal:  J Physiol Biochem       Date:  2016-10-22       Impact factor: 4.158

3.  Troxerutin Preconditioning and Ischemic Postconditioning Modulate Inflammatory Response after Myocardial Ischemia/Reperfusion Injury in Rat Model.

Authors:  Reza Badalzadeh; Behzad Baradaran; Alireza Alihemmati; Bahman Yousefi; Azam Abbaszadeh
Journal:  Inflammation       Date:  2017-02       Impact factor: 4.092

4.  Beneficial effect of troxerutin on diabetes-induced vascular damages in rat aorta: histopathological alterations and antioxidation mechanism.

Authors:  Reza Badalzadeh; Nayeleh Layeghzadeh; Alireza Alihemmati; Mustafa Mohammadi
Journal:  Int J Endocrinol Metab       Date:  2015-04-30

5.  Effect of ischemic postconditioning on myocardial protection in patients undergoing coronary artery bypass grafting surgery with cardiopulmonary bypass.

Authors:  Nasser Safaei; Mohammad Ali Sheikhalizadeh; Reza Badalzadeh
Journal:  J Cardiovasc Thorac Res       Date:  2016-06-28

6.  Application of ischemic postconditioning's algorithms in tissues protection: response to methodological gaps in preclinical and clinical studies.

Authors:  Saeid Feyzizadeh; Reza Badalzadeh
Journal:  J Cell Mol Med       Date:  2017-04-12       Impact factor: 5.310

7.  Combination of Vildagliptin and Ischemic Postconditioning in Diabetic Hearts as a Working Strategy to Reduce Myocardial Reperfusion Injury by Restoring Mitochondrial Function and Autophagic Activity.

Authors:  Goltaj Bayrami; Alireza Alihemmati; Pouran Karimi; Aniseh Javadi; Rana Keyhanmanesh; Mustafa Mohammadi; Milad Zadi-Heydarabad; Reza Badalzadeh
Journal:  Adv Pharm Bull       Date:  2018-06-19

8.  Cardioprotective effects of co-administration of thymoquinone and ischemic postconditioning in diabetic rats.

Authors:  Junchuan Ran; Huanglin Xu; Wenyuan Li
Journal:  Iran J Basic Med Sci       Date:  2021-07       Impact factor: 2.699

Review 9.  Remote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulceration.

Authors:  J A Epps; N A Smart
Journal:  Cardiovasc Diabetol       Date:  2016-09-09       Impact factor: 9.951

10.  Selective Inhibition of PKCβ2 Restores Ischemic Postconditioning-Mediated Cardioprotection by Modulating Autophagy in Diabetic Rats.

Authors:  Yafeng Wang; Lu Zhou; Wating Su; Fengnan Huang; Yuan Zhang; Zhong-Yuan Xia; Zhengyuan Xia; Shaoqing Lei
Journal:  J Diabetes Res       Date:  2020-04-03       Impact factor: 4.011

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.